Antitumor activity of mifepristone in the human LNCaP, LNCaP‐C4, and LNCaP‐C4‐2 prostate cancer models in nude mice

MF El Etreby, Y Liang, MH Johnson, RW Lewis - The Prostate, 2000 - Wiley Online Library
BACKGROUND Antiprogestins are a promising new class of mammary tumor inhibitors with
a unique mechanism of action. Previously published results also suggest a tumor‐inhibitory …
被引用次数：58 相关文章

Antitumor activity of mifepristone in the human LNCaP, LNCaP-C4, and LNCaP-C4-2 prostate cancer models in nude mice

MF El Etreby, Y Liang, MH Johnson, RW Lewis - Prostate, 2000 - hero.epa.gov
BACKGROUND: Antiprogestins are a promising new class of mammary tumor inhibitors with
a unique mechanism of action. Previously published results also suggest a tumor-inhibitory …

Antitumor activity of mifepristone in the human LNCaP, LNCaP-C4, and LNCaP-C4-2 prostate cancer models in nude mice.

MF El Etreby, Y Liang, MH Johnson, RW Lewis - The Prostate, 2000 - europepmc.org
Background Antiprogestins are a promising new class of mammary tumor inhibitors with a
unique mechanism of action. Previously published results also suggest a tumor-inhibitory …

Antitumor activity of mifepristone in the human LNCaP, LNCaP-C4, and LNCaP-C4-2 prostate cancer models in nude mice

MF El Etreby, Y Liang, MH Johnson… - Prostate, 2000 - augusta.elsevierpure.com
BACKGROUND. Antiprogestins are a promising new class of mammary tumor inhibitors with
a unique mechanism of action. Previously published results also suggest a tumor-inhibitory …

[引用][C] Antitumor activity of mifepristone in the human LNCaP, LNCaP-C4, and LNCaP-C4-2 prostate cancer models in nude mice

Y LIANG, MH JOHNSON, RW LEWIS - The Prostate, 2000 - pascal-francis.inist.fr
Antitumor activity of mifepristone in the human LNCaP, LNCaP-C4, and LNCaP-C4-2
prostate cancer models in nude mice CNRS Inist Pascal-Francis CNRS Pascal and Francis …

Antitumor activity of mifepristone in the human LNCaP, LNCaP-C4, and LNCaP-C4-2 prostate cancer models in nude mice

MF El Etreby, Y Liang, MH Johnson… - The …, 2000 - pubmed.ncbi.nlm.nih.gov
Background Antiprogestins are a promising new class of mammary tumor inhibitors with a
unique mechanism of action. Previously published results also suggest a tumor-inhibitory …